{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:35Z","timestamp":1761540335620,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1023\/a:1006619820040","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:51:24Z","timestamp":1040525484000},"page":"287-293","source":"Crossref","is-referenced-by-count":9,"title":["Humoral Immunity Against Glutamic Acid Decarboxylase and Tyrosine Phosphatase IA-2 in Lambert\u2013Eaton Myasthenic Syndrome"],"prefix":"10.1007","volume":"20","author":[{"given":"Laurence","family":"Hermitte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Martin-Moutot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Boucraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselyne","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Atlan-Gepner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00a8el","family":"Seagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Kleisbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00b8cois","family":"Couraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Vialettes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"223928_CR1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1432-1033.1996.435rr.x","volume":"242","author":"OD Madsen","year":"1996","unstructured":"Madsen OD, Jensen J, Blume N, Petresen HV, Lund K, Karlsen C, Andersen FG, Jensen P, Larsson LI, Serup P: Pancreatic development and maturation of the islet \u03b2 cell. Studies of pluripotent islet cultures. Eur J Biochem 242:435-445, 1996","journal-title":"Eur J Biochem"},{"key":"223928_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","volume":"347","author":"S Baekkeskov","year":"1990","unstructured":"Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Ritcher-Olesen H, Camilli PD: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990","journal-title":"Nature"},{"key":"223928_CR3","doi-asserted-by":"crossref","first-page":"8626","DOI":"10.1073\/pnas.92.19.8626","volume":"92","author":"F Rorsman","year":"1995","unstructured":"Rorsman F, Husebye ES, Winqvist O, Bj\u00f6rk E, Karlsson FA, K\u00e4mpe O: Aromatic L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme \u03b2 cell autoantigen. Proc Natl Acad Sci USA 92:8626-8629, 1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"223928_CR4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/j.1460-2075.1996.tb00564.x","volume":"15","author":"M Solimena","year":"1996","unstructured":"Solimena M, Dirkx R, Hermel JM, Pleasic-Williams S, Shapiro J, Caron L, Rabin D: ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15:2102-2114, 1996","journal-title":"EMBO J"},{"key":"223928_CR5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/dna.1994.13.505","volume":"13","author":"MS Lan","year":"1994","unstructured":"Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994","journal-title":"DNA Cell Biol"},{"key":"223928_CR6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diab.46.8.1270","volume":"46","author":"M Hawa","year":"1997","unstructured":"Hawa M, Row R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie R: Value of antibodies to islet protein tyrosine phosphataselike molecule in predicting type 1 diabetes. Diabetes 46:1270-1275, 1997","journal-title":"Diabetes"},{"key":"223928_CR7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diacare.20.9.1403","volume":"20","author":"S Feeney","year":"1997","unstructured":"Feeney S, Myers M, Mackay I, Zimmet P, Howard N, Verge C, Rowley M: Evaluation of ICA512Ab in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care 20:1403-1407, 1997","journal-title":"Diabetes Care"},{"key":"223928_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s001250050925","volume":"41","author":"K Savola","year":"1998","unstructured":"Savola K, Bonifacio E, Sabbah E, Kulmala P, V\u00e4h\u00e4salo P, Karjalainen J, Tuomilchto-Wolf E, Meril\u00e4inen J, Akerblom HK, Knip M, and the Childhood Diabetes in Finland Study Group: IA-2 antibodies\u2014A sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 41:424-429, 1998","journal-title":"Diabetologia"},{"key":"223928_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-5728(96)00104-X","volume":"69","author":"G Martino","year":"1996","unstructured":"Martino G, Grimaldi M, Bazzigaluppi E, Passini M, Sinigaglia M, Rogge L: The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients. J Neuroimmunol 69:129-134, 1996","journal-title":"J Neuroimmunol"},{"key":"223928_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/diab.46.4.565","volume":"46","author":"U Wiest-Ladenburger","year":"1997","unstructured":"Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, B\u00f6hm BO, Richter W: Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46:565-571, 1997","journal-title":"Diabetes"},{"issue":"S1","key":"223928_CR11","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/ana.410370708","volume":"37","author":"B Donald","year":"1995","unstructured":"Donald B, Sanders MD: Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol 37(S1):S63-S73, 1995","journal-title":"Ann Neurol"},{"key":"223928_CR12","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","volume":"80","author":"H Fukunaga","year":"1983","unstructured":"Fukunaga H, Engel AG, Lang B, Newsom-Davis J, Vincent A: Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane actives zones. Proc Natl Acad Sci USA 80:7636-7640, 1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"223928_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mus.880111105","volume":"11","author":"E Lambert","year":"1988","unstructured":"Lambert E, Lennon V: Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: Complement independence and EMG abnormalities. Muscle Nerve 11:1133-1145, 1988","journal-title":"Muscle Nerve"},{"key":"223928_CR14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"V Lennon","year":"1995","unstructured":"Lennon V, Kryzer T, Griesmann G, O'Suilleabhain P, Windebank J, Woppmann A, Miljanich G, Lambert E: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. New Engl J Med 332:1467-1474, 1995","journal-title":"New Engl J Med"},{"key":"223928_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"J Engelhardt","year":"1993","unstructured":"Engelhardt J, Tajti J, Appel S: Lymphocytic infiltrates in the spinal cord in amyotrophic lateral slerosis. Arch Neurol 50:30-36, 1993","journal-title":"Arch Neurol"},{"key":"223928_CR16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199212103272405","volume":"327","author":"R Smith","year":"1992","unstructured":"Smith R, Hamilton S, Hofmann F, Schneider T, Nastainczyk W, Birnbaumer L, Stefani E, Appel S: Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. New Engl J Med 327:1721-1728, 1992","journal-title":"New Engl J Med"},{"key":"223928_CR17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.410400504","volume":"40","author":"C Arsac","year":"1996","unstructured":"Arsac C, Raymond C, Martin-Moutot N, Dargent B, Couraud F, Pouget J, Seagar M: Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol 40:695-700, 1996","journal-title":"Ann Neurol"},{"key":"223928_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.iy.10.040192.001101","volume":"10","author":"R Martin","year":"1992","unstructured":"Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187, 1992","journal-title":"Annu Rev Immunol"},{"key":"223928_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00867354","volume":"240","author":"O Anderson","year":"1993","unstructured":"Anderson O, Lygner RE, Bergstrom T, et al: Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study. J Neurol 240:417-422, 1993","journal-title":"J Neurol"},{"key":"223928_CR20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archneur.55.4.517","volume":"55","author":"A Tourbah","year":"1998","unstructured":"Tourbah A, Clapin A, Gout O, Fontaine B, et al: Systemic autoimmune features and multiple sclerosis. A 5-year follow-up study. Arch Neurol 55:517-521, 1998","journal-title":"Arch Neurol"},{"key":"223928_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"JH O'Neill","year":"1988","unstructured":"O'Neill JH, Murray NMF, Newsom-Davies J: The Lambert-Eaton myasthenic syndrome: A review of 50 cases. Brain 111:557-296, 1988","journal-title":"Brain"},{"key":"223928_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Pathy DW, Scheinberg L, McDonald I, Danis FA, Ebers GC, Johnson KP, Sibley WA, Silberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 13:227-231, 1983","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"223928_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical limits of amyotrophic lateral sclerosis\u201d workshop contributors. J Neurol Sci 124(Suppl): 96-107, 1994","journal-title":"J Neurol Sci"},{"key":"223928_CR24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s001250050358","volume":"38","author":"E Bonifacio","year":"1995","unstructured":"Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, et al: Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822, 1995","journal-title":"Diabetologia"},{"key":"223928_CR25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<586::AID-DIA624>3.0.CO;2-B","volume":"15","author":"L Hermitte","year":"1998","unstructured":"Hermitte L, Atlan-Gepner C, Mattei C, Dufayet D, Jannot MF, Christofilis MA, Nervi S, Vialettes B: Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: No association with complications. Diabetes Med 15:586-591, 1998","journal-title":"Diabetes Med"},{"key":"223928_CR26","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1074\/jbc.271.12.6567","volume":"271","author":"N Martin-Moutot","year":"1996","unstructured":"Martin-Moutot N, Charvin N, Leveque C, Sato K, Nishiki T, Kosaki S, Takahashi M, Seagar M: Interaction of complexes with P\/Q-type calcium channel in rat cerebellar synaptosomes. J Biol Chem 271:6567-6570, 1996","journal-title":"J Biol Chem"},{"key":"223928_CR27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0387-7604(83)80080-1","volume":"5","author":"H Tada","year":"1983","unstructured":"Tada H: Glutamic acid decarboxylase in cerebrospinal fluid in infancy and childhood part II. Glutamic acid decarboxylase activity in cerebrospinal fluid of children with neurological diseases. Brain Dev 5:488-493, 1983","journal-title":"Brain Dev"},{"key":"223928_CR28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08916939708994729","volume":"25","author":"NG Morgenthaler","year":"1997","unstructured":"Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck HM, Christie MR: Antibodies to the tyrosine phosphataselike protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Autoimmunity 25:203-211, 1997","journal-title":"Autoimmunity"},{"key":"223928_CR29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archneur.1995.00540290050017","volume":"52","author":"J Honnorat","year":"1995","unstructured":"Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF: Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 52:462-468, 1995","journal-title":"Arch Neurol"},{"key":"223928_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/diab.43.1.161","volume":"43","author":"E Bj\u00f6rk","year":"1994","unstructured":"Bj\u00f6rk E, Velloso L, K\u00e4mpe O, Karlsson FA: GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type 1 recognize different epitopes. Diabetes 43:161-165, 1994","journal-title":"Diabetes"},{"key":"223928_CR31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.180.2.595","volume":"180","author":"J Kim","year":"1994","unstructured":"Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck C, Erlich H, Lennon V, Baekkeskov S: Higher antibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65A, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595-606, 1994","journal-title":"J Exp Med"},{"key":"223928_CR32","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.178.6.2097","volume":"178","author":"MH Butler","year":"1993","unstructured":"Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P: Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178:2097-2106, 1993","journal-title":"J Exp Med"},{"key":"223928_CR33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI116192","volume":"91","author":"M Atkinson","year":"1993","unstructured":"Atkinson M, Kaufman D, Newman D, Tobin A, Maclaren N: Islet cell cytoplasmic reactivity to glutamate decarboxylase in insulindependent diabetes. J Clin Invest 91:350-356, 1993","journal-title":"J Clin Invest"},{"key":"223928_CR34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.7686306","volume":"261","author":"L Juntti-Berggren","year":"1993","unstructured":"Juntti-Berggren L, Larsson O, Rorsman P, \u00c4mm\u00e4l\u00e4 C, Bokvist K, Wahlander K, Nicotera P, Dypbukt J, Orrenius S, Hallberg A, Beggren PO: Increased activity of L-type CA2+ channels exposed to serum from patients with type I diabetes. Sciences 261:86-90, 1993","journal-title":"Sciences"},{"key":"223928_CR35","first-page":"2742","volume":"56","author":"H Xie","year":"1996","unstructured":"Xie H, Notkins AL, Lan M: IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype. Cancer Research 56:2742-2744, 1996","journal-title":"Cancer Research"},{"key":"223928_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00396382","volume":"113","author":"G Bepler","year":"1987","unstructured":"Bepler G, Jaques G, Koehler A, Gropp C, Havemann K: Markers and characteristics of human SCLC cell lines. Neuroendocrine markers and chromosomal characteristics of permanent human cell lung cancer cell lines. J Cancer Res Clin Oncol 113:253-259, 1987","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006619820040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006619820040\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006619820040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T13:27:46Z","timestamp":1751030866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006619820040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["223928"],"URL":"https:\/\/doi.org\/10.1023\/a:1006619820040","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}